Valuation: Shandong Linuo Pharmaceutical Packaging Co., Ltd.

Market Cap 5.26B 788M 718M 664M 601M 1.13B 73.55B 1.18B 8.03B 3.18B 39.75B 2.95B 2.89B 126B P/E 2026 *
51.9x
P/E 2027 * 39.7x
Enterprise Value 5.26B 788M 718M 664M 601M 1.13B 73.55B 1.18B 8.03B 3.18B 39.75B 2.95B 2.89B 126B EV / Sales 2026 *
4.82x
EV / Sales 2027 * 4.25x
Free-Float
62.75%
Yield 2026 *
-
Yield 2027 * -
24/10 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026 CI
21/09 Shandong Linuo Pharmaceutical Packaging Co., Ltd.(XSEC:301188) added to S&P Global BMI Index CI
25/08 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
04/06 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2025, Payable on 9 June 2026 CI
23/04 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
22/04 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announces Annual dividend, payable on June 09, 2026 CI
21/04 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announced that it expects to receive CNY 300 million in funding CI
07/04 Nuode Fund Management Co., Ltd., Caitong Fund Management Co., Ltd., Jinxiu Zhonghe Investment Management Co., Ltd. and Allianz Asset Management Co., Ltd acquired 2.99% stake in Shandong Linuo Pharmaceutical Packaging Co., Ltd. from Linuo Investment Holding Group Co., Ltd. for approximately CNY 130 million. CI
31/03 Shandong Linuo Pharmaceutical Packaging's controlling shareholder plans to sell 3.0% stake RE
15/12 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
15/12 Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback announced on February 7, 2025, has closed with 4,557,700 shares, representing 1.99% for CNY 81.11 million. CI
04/11 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Approves Board Elections CI
27/10/25 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
1 day-2.36%
1 week-17.04%
Current month-9.92%
1 month-23.66%
3 months-55.34%
6 months-48.63%
Current year+15.11%
1 week 20.1
Extreme 20.10000000
24.56
1 month 20.1
Extreme 20.10000000
28.3
Current year 15.07
Extreme 15.07
76.3
1 year 15.07
Extreme 15.07
76.3
3 years 10.78
Extreme 10.78
76.3
5 years 10.78
Extreme 10.78
76.3
10 years 10.78
Extreme 10.78
76.3
Manager TitleAgeSince
Chief Executive Officer 46 15/04/2024
Director of Finance/CFO 45 29/11/2022
Investor Relations Contact - -
Director TitleAgeSince
Chairman 51 31/10/2025
Chairman 47 01/01/2024
Director/Board Member 54 06/04/2015
Change 5-day change 1-year change 3-year change Capi.($)
-2.36%-17.04%+16.57%+22.86% 807M
-2.84%-4.35%+0.38%-9.37% 20.18B
-2.10%-1.15%-5.79%+68.22% 19.69B
-2.16%-3.53%+33.58%+21.26% 16.89B
-2.50%-2.68%+8.54%-3.59% 14.18B
-1.42%-2.94%+24.40%+41.68% 12.83B
-0.11%+0.26%+19.95%+74.25% 11.79B
-0.94%-1.92%+17.63%+9.70% 8.98B
-1.11%-4.01%-6.09%-25.22% 7.98B
0.00%-1.04%+31.49%+608.70% 6.73B
Average -1.55%-2.04%+14.07%+80.85% 12B
Weighted average by Cap. -1.74%-1.01%+12.20%+57.26%

Financials

2026 *2027 *
Net sales 1.09B 163M 149M 138M 125M 234M 15.25B 245M 1.66B 660M 8.24B 613M 600M 26.11B 1.24B 185M 169M 156M 142M 265M 17.32B 278M 1.89B 750M 9.36B 696M 681M 29.65B
Net income 103M 15.43M 14.06M 13.02M 11.77M 22.09M 1.44B 23.12M 157M 62.41M 779M 57.9M 56.68M 2.47B 137M 20.53M 18.7M 17.31M 15.66M 29.38M 1.92B 30.75M 209M 83.01M 1.04B 77.01M 75.39M 3.28B
Net Debt - -
Projected Income Statement - Annual - Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Logo Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Shandong Linuo Pharmaceutical Packaging Co Ltd, formerly Shandong Linuo Technical Glass Co Ltd, is a China-based company specialized in the research, development, production and sales of borosilicate special glass. The Company's main products include medium borosilicate pharmaceutical glass and high borosilicate heat-resistant glass series products. Pharmaceutical glass products include low borosilicate pharmaceutical glass series and medium borosilicate pharmaceutical glass series, which are mainly used in medical packaging fields such as blood products, biopharmaceuticals, new drugs and special drugs, vaccines, etc. High borosilicate heat-resistant glass products include heat-resistant glassware, glass trays for microwave ovens, glass lenses, electric light source glass shells and electric light source glass tubes, and others, which are mainly used in residential life fields including dining utensils, kitchen utensils, lighting fixtures, and others.
Employees
1,403
Date Price Change Volume
19/11/26 CNY 20.26 -2.36% 4,316,900
18/11/26 CNY 20.75 0.00% 5,979,400
17/11/26 CNY 20.75 -0.81% 7,018,928
16/11/26 CNY 20.92 -8.45% 7,063,337
13/11/26 CNY 22.85 -4.95% 6,583,000

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Shandong Linuo Pharmaceutical Packaging Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 301188 Stock